vimarsana.com

Page 12 - இஸ்ரேல் நிறுவனம் க்கு உயிரியல் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Israel prepares vehicles for flu shots and mobile COVID-19 vaccines

Israel prepares vehicles for flu shots and mobile COVID-19 vaccines   A Magen David Adom vaccine caravan. (ISRAEL21c via JNS) - In preparation for the flu season and the arrival of COVID-19 vaccines needing special refrigeration, three mobile vaccination caravans were commissioned by Magen David Adom, Israel s national organization responsible for emergency pre-hospital medical care and blood services. Stationed at the National Operations Center in Kiryat Ono, near Tel Aviv, the six-meter (19.6-foot) caravans can offer flu vaccinations and coronavirus testing around the country until the COVID-19 vaccines are approved and shipped to Israel. Since the beginning of the coronavirus outbreak, MDA t.

What to do if you re involved in a clinical trial, now that there s a coronavirus vaccine

Follow Dec. 17, 2020 Israelis participating in clinical trials of a locally produced potential vaccine against the coronavirus can still get the vaccine made by Pfizer, health authorities clarified on Sunday. Clinical trials of any drug or vaccine involve controls: one group receives the actual active ingredient and another group gets a placebo, which has no biological effect. Under normal conditions, neither the tester nor the testee know in advance whether a subject received a real drug or placebo. Now however due to the circumstances, if a test subject wishes to receive the Pfizer inoculation, their file will be opened; if they received a placebo and not the Israeli vaccine, they will be informed accordingly. Placebo recipients can then get the Pfizer shot, explains Dr. Erez Birnbaum, CEO of the Assuta Ashdod Medical Center, which is one of the sites at which the Israeli vaccine is being tested.

Israeli Vaccine Completes Phase I Trials

CoronavirusIsrael By Hamodia Staff YERUSHALAYIM - Monday, December 14, 2020 at 3:45 pm | כ ח כסלו תשפ א Medical staff at the coronavirus ward of the Kaplan Medical Center, in Rehovot, Israel. (Yossi Aloni/Flash90) Israel’s own coronavirus vaccine project passed a milestone on Monday, as it completed Phase I of clinical trials and prepared to move on to Phase II. The Israel Institute for Biological Research (IIBR) Phase II is expected to begin in the coming days with the participation of approximately 1,000 volunteers at Sheba and Hadassah Medical Centers, then gradually expanding to additional medical centers throughout the country. Defense Minister, Benny Gantz said that “the scientists of the IIBR are Israel’s ‘elite unit,’ and have taken on an extremely important task – saving human lives. I see great importance in the development of an Israeli vaccine that will continue to serve Israeli society for years to come.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.